Oct 30 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2019 Sep 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.38 5.23 11.30
(+3.0 pct) (-3.6 pct) (+5.2 pct)
Operating loss 900 mln loss 44 mln loss 900 mln
Recurring loss 886 mln loss 29 mln loss 900 mln
Net loss 1.62 loss 31 mln loss 1.65
EPS loss 46.76 yen loss 0.91 yen loss 47.54 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T